0	7	RFLAT-1	rflat-1	NN
7	8	:	:	:
9	10	a	a	DT
11	14	new	new	JJ
15	19	zinc	zinc	NN
20	26	finger	finger	NN
27	40	transcription	transcription	NN
41	47	factor	factor	NN
48	52	that	that	WDT
53	62	activates	activate	VBZ
63	69	RANTES	RANTES	NNP
70	74	gene	gene	NN
75	85	expression	expression	NN
86	88	in	in	IN
89	90	T	t	NN
91	102	lymphocytes	lymphocyte	NNS
102	103	.	.	.

105	111	RANTES	RANTES	NNP
112	113	(	(	(
113	122	Regulated	regulate	VBN
123	127	upon	upon	IN
128	138	Activation	Activation	NNP
138	139	,	,	,
140	146	Normal	normal	JJ
147	148	T	t	NN
149	153	cell	cell	NN
154	163	Expressed	express	VBN
164	167	and	and	CC
168	176	Secreted	secrete	VBN
176	177	)	)	)
178	180	is	be	VBZ
181	182	a	a	DT
183	198	chemoattractant	chemoattractant	NN
199	207	cytokine	cytokine	NN
208	209	(	(	(
209	218	chemokine	chemokine	NN
218	219	)	)	)
220	229	important	important	JJ
230	232	in	in	IN
233	236	the	the	DT
237	247	generation	generation	NN
248	250	of	of	IN
251	263	inflammatory	inflammatory	JJ
264	274	infiltrate	infiltrate	NN
275	278	and	and	CC
279	284	human	human	JJ
285	301	immunodeficiency	immunodeficiency	NN
302	307	virus	virus	NN
308	313	entry	entry	NN
314	318	into	into	IN
319	325	immune	immune	JJ
326	331	cells	cell	NNS
331	332	.	.	.

333	339	RANTES	RANTES	NNP
340	342	is	be	VBZ
343	352	expressed	express	VBN
353	357	late	late	RB
358	359	(	(	(
359	362	3-5	3-5	CD
363	367	days	day	NNS
367	368	)	)	)
369	374	after	after	IN
375	385	activation	activation	NN
386	388	in	in	IN
389	390	T	t	NN
391	402	lymphocytes	lymphocyte	NNS
402	403	.	.	.

404	409	Using	use	VBG
410	420	expression	expression	NN
421	428	cloning	cloning	NN
428	429	,	,	,
430	432	we	we	PRP
433	443	identified	identify	VBD
444	447	the	the	DT
448	453	first	first	JJ
454	455	“	``	``
455	459	late	late	JJ
459	460	”	''	''
461	462	T	t	NN
463	473	lymphocyte	lymphocyte	NN
474	484	associated	associate	VBN
485	498	transcription	transcription	NN
499	505	factor	factor	NN
506	509	and	and	CC
510	515	named	name	VBD
516	518	it	it	PRP
519	520	“	``	``
520	526	RANTES	rantes	NN
527	533	Factor	factor	NN
534	536	of	of	IN
537	541	Late	late	JJ
542	551	Activated	activate	VBN
552	553	T	t	NN
554	567	Lymphocytes-1	lymphocytes-1	NN
567	568	”	''	''
569	570	(	(	(
570	577	RFLAT-1	RFLAT-1	NNP
577	578	)	)	)
578	579	.	.	.

580	587	RFLAT-1	RFLAT-1	NNP
588	590	is	be	VBZ
591	592	a	a	DT
593	598	novel	novel	JJ
598	599	,	,	,
600	614	phosphorylated	phosphorylate	VBN
614	615	,	,	,
616	620	zinc	zinc	NN
621	627	finger	finger	NN
628	641	transcription	transcription	NN
642	648	factor	factor	NN
649	653	that	that	WDT
654	656	is	be	VBZ
657	666	expressed	express	VBN
667	669	in	in	IN
670	671	T	t	NN
672	677	cells	cell	NNS
678	679	3	3	CD
680	684	days	day	NNS
685	690	after	after	IN
691	701	activation	activation	NN
701	702	,	,	,
703	713	coincident	coincident	JJ
714	718	with	with	IN
719	725	RANTES	RANTES	NNP
726	736	expression	expression	NN
736	737	.	.	.

738	743	While	while	IN
744	747	Rel	Rel	NNP
748	756	proteins	protein	NNS
757	761	play	play	VBP
762	765	the	the	DT
766	774	dominant	dominant	JJ
775	779	role	role	NN
780	782	in	in	IN
783	789	RANTES	RANTES	NNP
790	794	gene	gene	NN
795	805	expression	expression	NN
806	808	in	in	IN
809	820	fibroblasts	fibroblast	NNS
820	821	,	,	,
822	829	RFLAT-1	RFLAT-1	NNP
830	832	is	be	VBZ
833	834	a	a	DT
835	841	strong	strong	JJ
842	856	transactivator	transactivator	NN
857	860	for	for	IN
861	867	RANTES	rantes	NN
868	870	in	in	IN
871	872	T	t	NN
873	878	cells	cell	NNS
878	879	.	.	.